MRI biomarkers in osseous tumors.
J Magn Reson Imaging
; 50(3): 702-718, 2019 09.
Article
em En
| MEDLINE
| ID: mdl-30701624
ABSTRACT
Although radiography continues to play a critical role in osseous tumor assessment, there have been remarkable advances in cross-sectional imaging. MRI has taken a lead in this assessment due to high tissue contrast and spatial resolution, which are well suited for bone lesion assessment. More recently, although somewhat lagging other organ systems, quantitative parameters have shown promising potential as biomarkers for osseous tumors. Among these sequences are chemical shift imaging (CSI), apparent diffusion coefficient (ADC), and intravoxel incoherent motion (IVIM) from diffusion-weighted imaging (DWI), quantitative dynamic contrast enhanced (DCE)-MRI, and magnetic resonance spectroscopy (MRS). In this article, we review the background and recent roles of these quantitative MRI biomarkers for osseous tumors. Level of Evidence 3 Technical Efficacy Stage 3 J. MAGN. RESON. IMAGING 2019. J. Magn. Reson. Imaging 2019;50702-718.
Palavras-chave
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Neoplasias Ósseas
/
Imageamento por Ressonância Magnética
/
Interpretação de Imagem Assistida por Computador
Limite:
Humans
Idioma:
En
Ano de publicação:
2019
Tipo de documento:
Article